TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Dne Pharma AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
46,724
|
40,356
|
31,491 |
Financial expenses |
2,158
|
1,998
|
16,437 |
Earnings before taxes |
8,562
|
6,285
|
-14,034 |
Total assets |
91,487
|
75,668
|
76,926 |
Current assets |
41,065
|
33,928
|
20,079 |
Current liabilities |
29,635
|
20,220
|
26,054 |
Equity capital |
52,863
|
46,026
|
41,296 |
- share capital |
142
![]() |
142
![]() |
142 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
57.8%
|
60.8%
|
53.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
18.3%
|
15.6%
|
-44.6% |
Return on assets (ROA) |
11.7%
|
10.9%
|
3.1% |
Current ratio |
138.6%
|
167.8%
|
77.1% |
Return on equity (ROE) |
16.2%
|
13.7%
|
-34.0% |
Change turnover |
6,368
|
8,865
|
3,323 |
Change turnover % |
16%
|
28%
|
12% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.